Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether G Medical Innovations Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as G Medical Innovations Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
G Medical Innovations Holdings. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
G Medical Innovations Holdings's
is considered below, and whether this is a fair price.
Price based on past earnings
G Medical Innovations Holdings's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as G Medical Innovations Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
G Medical Innovations Holdings
expected to grow at an
Unable to compare G Medical Innovations Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare G Medical Innovations Holdings's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare G Medical Innovations Holdings's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if G Medical Innovations Holdings is high growth as no earnings estimate data is available.
Unable to determine if G Medical Innovations Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access G Medical Innovations Holdings's filings and announcements here.
All data from G Medical Innovations Holdings Company Filings, last reported 3 months ago, and in
Trailing twelve months (TTM)
annual period rather than quarterly.
OTCPK:GMMV.F Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions)
Net Income *
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
It is difficult to establish if G Medical Innovations Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
It is difficult to establish if G Medical Innovations Holdings has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
It is difficult to establish if G Medical Innovations Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
G Medical Innovations Holdings's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
G Medical Innovations Holdings
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
G Medical Innovations Holdings's finances.
The net worth of a company is the difference between its assets and liabilities.
G Medical Innovations Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
G Medical Innovations Holdings's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
G Medical Innovations Holdings's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
G Medical Innovations Holdings has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Dr. Yacov Geva serves as the Chief Executive Officer, President and Executive Director of G Medical Innovations Holdings Limited since October 3, 2014. Dr. Geva was the Co-Founder of LifeWatch AG and served as its Chief Executive Officer from 1999 to March 31, 2010. He served as Chief Executive Officer of LifeWatch AG until January 30, 2014 and served as its interim Chief Executive Officer since November 3, 2010 and Members of the Executive Board. He served as Chief Executive Officer of LifeWatch Services, Inc. (alternate name, LifeWatch Holding) at LifeWatch Corp. from July 2005 to July 2006 and served as its Chairman. Dr. Geva served as Chief Executive Officer of LifeWatch Corp. Dr. Geva has been managing Card Guard from its formation in 1990, through its floatation on the Swiss stock exchange in November 1999 and continues to lead it through acquisitions and strategic alliances. Prior to Card Guard, he served as a Chief Mechanical Engineer with Vishay Israel Limited, a subsidiary of Vishay Intertechnology, USA, from 1979 to 1989. From 1976 to 1979, he was in Koor Industries Limited (Koor Industries Group) as a special projects manager for electronic communication projects. He served as the Chairman of LifeWatch AG from 1999 to July 2013 and LifeWatch Corp. He serves as Member of Advisory Board at Columbine Ventures. He serves as Director of LifeWatch Corp. and Sensei, Inc. He served as Director of LifeWatch AG from 1989 to January 30, 2014. Dr. Geva is also a senior member of the royal society of medicine in the UK (RSM). Dr. Geva is a graduate of the Technion-Israeli Institute of Technology and holds a B.Sc. in Mechanical and Nuclear engineering and a Ph.D. (with honours) in Business Administration from the International School of Management, Paris, France. He holds an Honorary Doctorate from Oxford Brooks University.
Insufficient data for Yacov to compare compensation growth.
Yacov's remuneration is lower than average for companies of similar size in United States of America.
CEO, President & Executive Director
President & COO
Chief Financial Officer
Chief Technology Officer
Senior Investment Banker and Senior VP of Merger & Acquisition
Board of Directors Tenure
Average tenure and age of the
G Medical Innovations Holdings
board of directors in years:
The average tenure for the G Medical Innovations Holdings board of directors is less than 3 years, this suggests a new board.
G Medical Innovations Holdings Ltd operates as a mobile health and e-health company. It develops and markets clinical and consumer medical-grade health monitoring solutions. The company develops Medical Smartphone Case, a solution that turns a phone into a mobile medical monitoring device; and G Medical Patch, a solution that provides continuous and real-time monitoring of a range of vital signs and biometrics. G Medical Innovations Holdings Ltd was founded in 2014 and is based in George Town, Cayman Islands.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.